FTC ANALYSES OF ECKERD/THRIFT, RITE AID/REVCO REFLECT AGENCY CONCERN ABOUT MAINTAINING VIABLE CHAINS; TIME TO COMPLETION OF DIVESTITURES DOWN -- FTC's CARY
The average time for completion of divestitures ordered by the Federal Trade Commission has dropped to 10 months, FTC Deputy Director for Mergers George Cary told the Corporate Counsel Institute in Atlanta Dec. 12.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth